Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancer.

× No keyword cloud information.

6 in total

1. Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.

Authors: Sai-Hong Ignatius Ou; Karen R Sommers; Michele C Azada; Edward B Garon
Journal: Oncologist Date: 2015-01-07

2. Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib.

Authors: Justin F Gainor; Carol A Sherman; Kathryn Willoughby; Jennifer Logan; Elizabeth Kennedy; Priscilla K Brastianos; Andrew S Chi; Alice T Shaw
Journal: J Thorac Oncol Date: 2015-02 Impact factor: 15.609

Review 3. Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.

Authors: Katharine Hall Thomas; Robert A Ramirez
Journal: Ochsner J Date: 2017

Review 4. Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.

Authors: Dae-Won Lee; Kyung-Hun Lee; Jin Wook Kim; Bhumsuk Keam
Journal: Int J Mol Sci Date: 2016-07-05 Impact factor: 5.923

Review 5. Leptomeningeal disease: current diagnostic and therapeutic strategies.

Authors: Gautam Nayar; Tiffany Ejikeme; Pakawat Chongsathidkiet; Aladine A Elsamadicy; Kimberly L Blackwell; Jeffrey M Clarke; Shivanand P Lad; Peter E Fecci
Journal: Oncotarget Date: 2017-08-16

6. [Management of Drug Therapy for Leptomeningeal Metastasis of Sensitive Driver Gene Positive Non-small Cell Lung Cancer].

Authors: Zhiqin Lu; Jing Cai; Zhimin Zeng; Anwen Liu
Journal: Zhongguo Fei Ai Za Zhi Date: 2020-08-06

6 in total